| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Intensive Care Units, Neonatal | 5 | 2020 | 749 | 1.72 | Why? |
| Cystic Fibrosis | 9 | 2019 | 1104 | 1.43 | Why? |
| Nurseries, Hospital | 1 | 2020 | 26 | 0.88 | Why? |
| Long-Term Care | 6 | 2020 | 2047 | 0.83 | Why? |
| Antimicrobial Stewardship | 6 | 2018 | 931 | 0.79 | Why? |
| Rubulavirus | 1 | 2018 | 5 | 0.78 | Why? |
| Delivery Rooms | 1 | 2020 | 148 | 0.77 | Why? |
| Paramyxoviridae Infections | 2 | 2018 | 364 | 0.72 | Why? |
| Respirovirus | 1 | 2018 | 122 | 0.72 | Why? |
| Vancomycin-Resistant Enterococci | 1 | 2017 | 104 | 0.63 | Why? |
| Organizational Policy | 2 | 2020 | 694 | 0.61 | Why? |
| Text Messaging | 1 | 2020 | 389 | 0.59 | Why? |
| Staphylococcal Infections | 3 | 2019 | 1099 | 0.55 | Why? |
| Bronchoalveolar Lavage | 1 | 2017 | 603 | 0.50 | Why? |
| Sentinel Surveillance | 1 | 2020 | 1093 | 0.49 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 1316 | 0.48 | Why? |
| Respiratory Tract Infections | 5 | 2020 | 6817 | 0.48 | Why? |
| Anti-Bacterial Agents | 12 | 2018 | 10083 | 0.45 | Why? |
| Gram-Negative Bacterial Infections | 2 | 2007 | 398 | 0.44 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2018 | 2309 | 0.44 | Why? |
| Interdisciplinary Studies | 1 | 2011 | 95 | 0.43 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 711 | 0.43 | Why? |
| Schools, Nursing | 1 | 2011 | 66 | 0.41 | Why? |
| Neonatology | 1 | 2010 | 84 | 0.40 | Why? |
| Respiratory Tract Diseases | 1 | 2017 | 1061 | 0.38 | Why? |
| Equipment Contamination | 3 | 2018 | 1308 | 0.36 | Why? |
| Ralstonia | 1 | 2007 | 3 | 0.36 | Why? |
| Patient Education as Topic | 1 | 2018 | 1476 | 0.35 | Why? |
| Methicillin | 1 | 2007 | 73 | 0.35 | Why? |
| Methicillin Resistance | 1 | 2007 | 77 | 0.35 | Why? |
| Nursing Research | 1 | 2011 | 181 | 0.34 | Why? |
| Infection Control | 5 | 2020 | 23131 | 0.32 | Why? |
| Staphylococcus aureus | 2 | 2017 | 844 | 0.32 | Why? |
| Child | 27 | 2020 | 70012 | 0.31 | Why? |
| Infant, Premature, Diseases | 1 | 2006 | 74 | 0.30 | Why? |
| New York City | 10 | 2021 | 7432 | 0.29 | Why? |
| Hospitals, Pediatric | 4 | 2020 | 1792 | 0.29 | Why? |
| Infant, Newborn | 14 | 2021 | 23105 | 0.28 | Why? |
| Guideline Adherence | 1 | 2018 | 2309 | 0.28 | Why? |
| Infant, Low Birth Weight | 1 | 2006 | 243 | 0.28 | Why? |
| Pseudomonas aeruginosa | 3 | 2018 | 652 | 0.27 | Why? |
| Pediatrics | 4 | 2020 | 2969 | 0.27 | Why? |
| Residential Facilities | 2 | 2020 | 443 | 0.26 | Why? |
| Health Care Surveys | 3 | 2018 | 2942 | 0.26 | Why? |
| Age of Onset | 3 | 2018 | 557 | 0.25 | Why? |
| Child, Preschool | 15 | 2020 | 36283 | 0.25 | Why? |
| Communicable Diseases, Emerging | 1 | 2017 | 2523 | 0.24 | Why? |
| Housekeeping, Hospital | 2 | 2019 | 37 | 0.24 | Why? |
| Masks | 4 | 2020 | 8528 | 0.23 | Why? |
| New York | 3 | 2018 | 2488 | 0.22 | Why? |
| Immunocompromised Host | 2 | 2018 | 5150 | 0.22 | Why? |
| Pneumonia, Bacterial | 2 | 2018 | 843 | 0.21 | Why? |
| Infant | 12 | 2020 | 30274 | 0.21 | Why? |
| Hernias, Diaphragmatic, Congenital | 1 | 2020 | 54 | 0.21 | Why? |
| Baths | 1 | 2020 | 62 | 0.21 | Why? |
| Microbial Sensitivity Tests | 3 | 2018 | 2886 | 0.20 | Why? |
| Patient Safety | 4 | 2019 | 4885 | 0.20 | Why? |
| Metapneumovirus | 2 | 2018 | 465 | 0.18 | Why? |
| RNA, Bacterial | 1 | 2018 | 116 | 0.18 | Why? |
| Hypertension, Portal | 1 | 2019 | 73 | 0.18 | Why? |
| Clinical Competence | 3 | 2018 | 3263 | 0.18 | Why? |
| Thienamycins | 1 | 2018 | 72 | 0.18 | Why? |
| Clinical Trials Data Monitoring Committees | 1 | 2018 | 58 | 0.18 | Why? |
| Colony Count, Microbial | 1 | 2018 | 177 | 0.17 | Why? |
| Intubation, Gastrointestinal | 1 | 2018 | 77 | 0.17 | Why? |
| Adolescent | 15 | 2020 | 86841 | 0.17 | Why? |
| Scoliosis | 1 | 2018 | 45 | 0.17 | Why? |
| Aztreonam | 1 | 2016 | 15 | 0.17 | Why? |
| Vancomycin Resistance | 1 | 2017 | 55 | 0.17 | Why? |
| Tobramycin | 1 | 2016 | 18 | 0.17 | Why? |
| Multiple Chronic Conditions | 1 | 2018 | 115 | 0.17 | Why? |
| Organizations, Nonprofit | 1 | 2018 | 87 | 0.17 | Why? |
| Enterococcus | 1 | 2017 | 73 | 0.17 | Why? |
| Attitude of Health Personnel | 2 | 2018 | 4741 | 0.17 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.17 | Why? |
| Pediatric Nursing | 1 | 2017 | 76 | 0.16 | Why? |
| Influenza, Human | 3 | 2018 | 10779 | 0.16 | Why? |
| Infectious Disease Transmission, Vertical | 4 | 2021 | 5164 | 0.16 | Why? |
| Microbiological Techniques | 1 | 2018 | 232 | 0.15 | Why? |
| Cross Infection | 3 | 2019 | 8675 | 0.15 | Why? |
| Pregnancy Complications, Infectious | 5 | 2021 | 11559 | 0.15 | Why? |
| Surgical Wound Infection | 2 | 2018 | 501 | 0.15 | Why? |
| Adenosine Triphosphate | 1 | 2018 | 294 | 0.15 | Why? |
| Seasons | 2 | 2018 | 4071 | 0.15 | Why? |
| Practice Guidelines as Topic | 3 | 2020 | 15421 | 0.15 | Why? |
| Quality Assurance, Health Care | 2 | 2017 | 596 | 0.15 | Why? |
| RNA, Ribosomal, 16S | 1 | 2018 | 793 | 0.14 | Why? |
| Inservice Training | 1 | 2019 | 477 | 0.14 | Why? |
| Enteral Nutrition | 1 | 2018 | 320 | 0.14 | Why? |
| Work Engagement | 1 | 2017 | 154 | 0.14 | Why? |
| Child Health Services | 2 | 2020 | 520 | 0.14 | Why? |
| Humans | 47 | 2021 | 930598 | 0.14 | Why? |
| Disabled Children | 1 | 2017 | 178 | 0.14 | Why? |
| Bacterial Infections | 3 | 2018 | 2229 | 0.13 | Why? |
| Organizational Culture | 1 | 2017 | 395 | 0.13 | Why? |
| Female | 28 | 2021 | 380317 | 0.13 | Why? |
| Visitors to Patients | 1 | 2020 | 671 | 0.13 | Why? |
| Multiplex Polymerase Chain Reaction | 2 | 2018 | 1439 | 0.13 | Why? |
| Feasibility Studies | 2 | 2020 | 3467 | 0.13 | Why? |
| Mandatory Programs | 1 | 2017 | 291 | 0.13 | Why? |
| Gynecology | 1 | 2020 | 741 | 0.12 | Why? |
| Male | 24 | 2021 | 367725 | 0.12 | Why? |
| Skilled Nursing Facilities | 2 | 2018 | 1098 | 0.12 | Why? |
| Pseudomonas Infections | 1 | 2016 | 425 | 0.12 | Why? |
| Patient Participation | 1 | 2019 | 829 | 0.12 | Why? |
| Respiratory Syncytial Virus Infections | 2 | 2018 | 1234 | 0.11 | Why? |
| United States | 9 | 2018 | 46150 | 0.11 | Why? |
| Obstetrics | 1 | 2020 | 859 | 0.11 | Why? |
| Prospective Studies | 5 | 2020 | 43301 | 0.11 | Why? |
| Risk Factors | 7 | 2018 | 71621 | 0.11 | Why? |
| Influenza Vaccines | 2 | 2018 | 2941 | 0.11 | Why? |
| Health Personnel | 3 | 2020 | 29646 | 0.11 | Why? |
| Heart Defects, Congenital | 1 | 2020 | 933 | 0.11 | Why? |
| Surgery Department, Hospital | 1 | 2020 | 954 | 0.11 | Why? |
| Young Adult | 11 | 2021 | 93724 | 0.11 | Why? |
| Delivery of Health Care | 1 | 2017 | 15909 | 0.10 | Why? |
| Hand Hygiene | 2 | 2019 | 1493 | 0.10 | Why? |
| Perioperative Care | 1 | 2020 | 1329 | 0.10 | Why? |
| Attitude | 1 | 2019 | 1481 | 0.10 | Why? |
| Education, Nursing, Graduate | 1 | 2011 | 80 | 0.10 | Why? |
| Breast Feeding | 1 | 2020 | 1585 | 0.10 | Why? |
| Health Facilities | 1 | 2017 | 1230 | 0.09 | Why? |
| Logistic Models | 3 | 2018 | 9089 | 0.09 | Why? |
| Sepsis | 1 | 2006 | 3517 | 0.09 | Why? |
| Safety Management | 1 | 2017 | 1093 | 0.09 | Why? |
| Virus Diseases | 2 | 2018 | 3779 | 0.09 | Why? |
| Pilot Projects | 1 | 2020 | 5182 | 0.09 | Why? |
| Hospitals | 5 | 2018 | 11793 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2017 | 1414 | 0.09 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2018 | 13720 | 0.09 | Why? |
| Staphylococcus | 2 | 2018 | 77 | 0.09 | Why? |
| Pregnancy Outcome | 1 | 2021 | 3803 | 0.08 | Why? |
| Lung Transplantation | 1 | 2019 | 1554 | 0.08 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.08 | Why? |
| Liver Cirrhosis | 1 | 2019 | 1810 | 0.08 | Why? |
| Workflow | 1 | 2017 | 2373 | 0.08 | Why? |
| Personal Protective Equipment | 3 | 2020 | 15978 | 0.08 | Why? |
| Pharmacists | 1 | 2018 | 1246 | 0.08 | Why? |
| Orthopedic Procedures | 1 | 2018 | 1231 | 0.08 | Why? |
| Patient Selection | 2 | 2019 | 4560 | 0.08 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.08 | Why? |
| Health Knowledge, Attitudes, Practice | 3 | 2018 | 8811 | 0.08 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.08 | Why? |
| Drug Resistance, Microbial | 1 | 2010 | 419 | 0.08 | Why? |
| Organ Transplantation | 1 | 2021 | 2616 | 0.08 | Why? |
| Disinfection | 1 | 2019 | 2912 | 0.07 | Why? |
| Personnel, Hospital | 1 | 2019 | 2273 | 0.07 | Why? |
| Community-Acquired Infections | 1 | 2018 | 2328 | 0.07 | Why? |
| Environmental Monitoring | 1 | 2018 | 3143 | 0.07 | Why? |
| Hospitalization | 5 | 2021 | 54280 | 0.07 | Why? |
| Anti-Infective Agents | 1 | 2017 | 1766 | 0.07 | Why? |
| Cough | 1 | 2018 | 4891 | 0.07 | Why? |
| Adult | 9 | 2021 | 244371 | 0.07 | Why? |
| Viruses | 1 | 2018 | 2238 | 0.07 | Why? |
| Inappropriate Prescribing | 2 | 2018 | 284 | 0.07 | Why? |
| Nursing Staff, Hospital | 1 | 2018 | 1554 | 0.07 | Why? |
| Pregnancy | 6 | 2021 | 23879 | 0.07 | Why? |
| Tertiary Care Centers | 2 | 2018 | 8248 | 0.06 | Why? |
| Leadership | 1 | 2017 | 2241 | 0.06 | Why? |
| Psychotic Disorders | 1 | 2013 | 924 | 0.06 | Why? |
| Liver Transplantation | 1 | 2019 | 2864 | 0.06 | Why? |
| Educational Measurement | 1 | 2011 | 930 | 0.06 | Why? |
| Postoperative Complications | 1 | 2021 | 5861 | 0.06 | Why? |
| Aerosols | 1 | 2018 | 5393 | 0.06 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2013 | 1380 | 0.06 | Why? |
| Azithromycin | 1 | 2016 | 3943 | 0.06 | Why? |
| Forecasting | 2 | 2019 | 4492 | 0.06 | Why? |
| Trisomy 13 Syndrome | 1 | 2020 | 26 | 0.06 | Why? |
| Surgical Attire | 1 | 2020 | 36 | 0.05 | Why? |
| Rooming-in Care | 1 | 2020 | 53 | 0.05 | Why? |
| Respiratory Syncytial Virus, Human | 2 | 2018 | 846 | 0.05 | Why? |
| Infant, Premature | 1 | 2006 | 883 | 0.05 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.05 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Virulence | 1 | 2007 | 2172 | 0.05 | Why? |
| Chloride Channel Agonists | 1 | 2019 | 10 | 0.05 | Why? |
| Veillonella | 1 | 2018 | 8 | 0.05 | Why? |
| Nurse's Role | 2 | 2018 | 614 | 0.05 | Why? |
| Haemophilus | 1 | 2018 | 13 | 0.05 | Why? |
| Culture Techniques | 1 | 2018 | 36 | 0.05 | Why? |
| Pseudomonas | 1 | 2018 | 65 | 0.05 | Why? |
| Gloves, Protective | 1 | 2020 | 249 | 0.05 | Why? |
| Disease Outbreaks | 1 | 2007 | 27595 | 0.05 | Why? |
| Corynebacterium | 1 | 2018 | 47 | 0.05 | Why? |
| Streptococcus | 1 | 2018 | 76 | 0.05 | Why? |
| Biomedical Research | 1 | 2019 | 5270 | 0.05 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.05 | Why? |
| Physicians | 1 | 2018 | 4214 | 0.04 | Why? |
| Legionella | 1 | 2018 | 91 | 0.04 | Why? |
| Severity of Illness Index | 4 | 2020 | 48226 | 0.04 | Why? |
| Prenatal Diagnosis | 1 | 2020 | 345 | 0.04 | Why? |
| Eye Protective Devices | 1 | 2020 | 245 | 0.04 | Why? |
| Enterococcus faecalis | 1 | 2017 | 126 | 0.04 | Why? |
| Luminescence | 1 | 2018 | 236 | 0.04 | Why? |
| Catheters, Indwelling | 1 | 2017 | 84 | 0.04 | Why? |
| Drug Administration Routes | 1 | 2016 | 106 | 0.04 | Why? |
| Postnatal Care | 1 | 2020 | 346 | 0.04 | Why? |
| Infant, Newborn, Diseases | 1 | 2020 | 394 | 0.04 | Why? |
| Evaluation Studies as Topic | 1 | 2018 | 391 | 0.04 | Why? |
| Bacteriological Techniques | 1 | 2018 | 239 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.04 | Why? |
| Surveys and Questionnaires | 4 | 2018 | 43792 | 0.03 | Why? |
| Carbapenems | 1 | 2017 | 343 | 0.03 | Why? |
| Developed Countries | 1 | 2018 | 500 | 0.03 | Why? |
| Disability Evaluation | 1 | 2017 | 671 | 0.03 | Why? |
| Catheter-Related Infections | 1 | 2017 | 381 | 0.03 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.03 | Why? |
| Comorbidity | 1 | 2018 | 34796 | 0.03 | Why? |
| Postoperative Care | 1 | 2019 | 755 | 0.03 | Why? |
| Clinical Trials as Topic | 2 | 2018 | 7330 | 0.03 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.03 | Why? |
| Clostridium Infections | 1 | 2019 | 595 | 0.03 | Why? |
| Klebsiella pneumoniae | 1 | 2017 | 658 | 0.03 | Why? |
| Spatio-Temporal Analysis | 1 | 2018 | 1182 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.03 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.03 | Why? |
| Intensive Care Units | 1 | 2017 | 29594 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2017 | 11304 | 0.03 | Why? |
| Bronchoscopy | 1 | 2018 | 991 | 0.03 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.03 | Why? |
| Biopsy | 1 | 2019 | 2811 | 0.02 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2017 | 861 | 0.02 | Why? |
| Respiratory Function Tests | 1 | 2016 | 1755 | 0.02 | Why? |
| Consumer Health Information | 1 | 2018 | 750 | 0.02 | Why? |
| Drug Interactions | 1 | 2016 | 1653 | 0.02 | Why? |
| Age Distribution | 1 | 2019 | 3567 | 0.02 | Why? |
| Preoperative Care | 1 | 2019 | 1515 | 0.02 | Why? |
| Coronavirus | 1 | 2018 | 18339 | 0.02 | Why? |
| Drug Monitoring | 1 | 2016 | 1408 | 0.02 | Why? |
| Microbiota | 1 | 2018 | 1240 | 0.02 | Why? |
| Medical Staff, Hospital | 1 | 2018 | 1258 | 0.02 | Why? |
| Data Collection | 1 | 2017 | 1769 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Needs Assessment | 1 | 2017 | 2352 | 0.02 | Why? |
| Treatment Outcome | 3 | 2019 | 51732 | 0.02 | Why? |
| Case-Control Studies | 1 | 2006 | 17671 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Patient Care | 1 | 2018 | 1664 | 0.02 | Why? |
| Perception | 1 | 2018 | 2827 | 0.02 | Why? |
| Quality of Health Care | 1 | 2018 | 1948 | 0.02 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Aged | 2 | 2021 | 215776 | 0.02 | Why? |
| Academic Medical Centers | 1 | 2018 | 3088 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Time Factors | 2 | 2019 | 31397 | 0.02 | Why? |
| Liver | 1 | 2019 | 4007 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
| Survival Rate | 1 | 2019 | 9206 | 0.02 | Why? |
| Parents | 1 | 2018 | 2758 | 0.02 | Why? |
| Global Health | 1 | 2007 | 13911 | 0.02 | Why? |
| Referral and Consultation | 1 | 2019 | 4816 | 0.02 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Time-to-Treatment | 1 | 2019 | 5883 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2019 | 53120 | 0.01 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.01 | Why? |
| Survival Analysis | 1 | 2013 | 7592 | 0.01 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.01 | Why? |
| Kidney | 1 | 2013 | 3648 | 0.01 | Why? |
| Nasopharynx | 1 | 2018 | 10224 | 0.01 | Why? |
| Registries | 1 | 2018 | 12327 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Lung | 1 | 2018 | 31049 | 0.01 | Why? |